Dr. Danso is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5900 Lake Wright Dr
Norfolk, VA 23502Phone+1 757-466-8683Fax+1 757-466-8892
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2002
Royal Free Hospital and University College London Medical SchoolClass of 1996
Certifications & Licensure
VA State Medical License 2007 - 2024
FL State Medical License 2005 - 2017
NY State Medical License 2002 - 2007
PA State Medical License 2000 - 2002- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations Start of enrollment: 2010 Feb 01
- Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women Start of enrollment: 2014 Mar 11
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) Start of enrollment: 2013 Oct 14
- Join now to see all
Publications & Presentations
PubMed
- 167 citationsAntiemetics: ASCO Guideline Update.Paul J. Hesketh, Mark G. Kris, Ethan Basch, Kari Bohlke, Sally Y. Barbour
Journal of Clinical Oncology. 2020-07-13 - 476 citationsPhase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast CancerAyca Gucalp, Sara M. Tolaney, Steven J. Isakoff, James N. Ingle, Minetta C. Liu
Clinical Cancer Research. 2013-10-01 - 56 citationsPathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signalingFrankie A. Holmes, Virginia Espina, Lance A. Liotta, Yasir Nagarwala, Michael A. Danso
BMC Research Notes. 2013-12-05
Press Mentions
GHS Sets up Committee to Investigate Death of Supposed Covid-19 PatientAugust 21st, 2021
Panic as Effia Nkwanta Hospital Runs of Out BloodApril 25th, 2020
Abura Dunkwa District Hospital Cries for DoctorsApril 17th, 2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
